2014 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

 I. Introduction

II. Hepatitis Worldwide Market and Technology Overview

A. Background

B. Hepatitis A

C. Hepatitis B

D. Hepatitis C

•  Classification


•  Transmission of Infection


•  Occupational Hazards


•  Acute Hepatitis


•  Diagnosis of Acute Infection


•  Chronic Hepatitis


•  HCV and Other Chronic Liver Diseases


•  Alcoholic Liver Disease


•  Hepatitis B Coinfection


•  Cirrhosis and Hepatocellular Carcinoma


•  Diagnostic Tests


•  Possible Indications for HCV RNA Testing


•  Conclusions and Future Direction

E. Hepatitis D

•  Historical Perspective


•  Epidemiology


•  HBV-HDV "Coinfection" vs. "Superinfection"


•  Methods of Detecting HDV


•  Prevention

F. Hepatitis E

•  Background


•  Prevalence of the Disease


•  Diagnostic Tests


•  Epidemiologic Serosurveys


•  Serologic Cross-Reactivity

G. Hepatitis G

•  Vaccines and Drugs

H. Review of Leading Analyzers Marketed by: Abbott, Beckman 

 Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, 

 Siemens, Tosoh, Wallac and Other Suppliers

I. Emerging Diagnostic Technologies

  1. Molecular Diagnostics

  2. Monoclonal Antibodies

  3. Immunoassays

  4. Differential Light Scattering

  5. Information Technology

  6. Artificial Intelligence

  7. Liposomes

  8. Flow Cytometry

  9. Chromatography

 10. Diagnostic Imaging

 11. Gel Microdroplets

 12. Other

III. USA: Market Size, Growth and Major Suppliers’ 

 Sales and Market Shares

X. Alternative Market Penetration Strategies

 A. Internal Development

 B. Collaborative Arrangements

 C. University Contracts

 D. Distribution Strategies for Decentralized Testing Markets

   1. Marketing Approaches

   2. Product Complexity

   3. Customer Preference

   4. Established Suppliers

   5. Emerging Suppliers

   6. Major Types of Distributors

   7. Market Segmentation

XI. Potential Market Entry Barriers and Risks

 A. Market Maturity

 B. Cost Containment

 C. Competition

 D. Technological Edge and Limitations

 E. Patent Protection

 F. Regulatory Constraints

 G. Decentralized Testing Market Challenges

XII. Competitive Assessments

- Abbott

- Affymetrix 

- Beckman Coulter/Danaher

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Enzo Biochem

- Fujirebio/Innogenetics

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech

- Life Technology

- Lonza

- Nanogen/Elitech

- Novartis Diagnostics

 - Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens 

- Takara Bio

- Thermo Fisher 

- Wallac/PE

- Wako

Major Companies Developing or Marketing Hepatitis Tests

U.S.A

HAV NAT Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A

HBV NAT Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

HBs Ag Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Hepatitis C Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Anti-HBc Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Anti-HBs Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Anti-HAV Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Hepatitis Delta Test Volume and Diagnostics Sales 

Forecast by Market Segment

U.S.A.

HBc Ag Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

HBe Ag Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

ALT/SGPT Test Volume and Diagnostics Sales Forecast 

by Market Segment

U.S.A.

Hepatitis Testing Market Diagnostics Sales 

by Major Supplier

U.S.A.

Hepatitis C Testing Market Diagnostics Sales 

by Major Supplier

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.